Cleared Traditional

K152516 - BD BBL Sensi-Disc Ceftazidime Avibactam (30/20ug), Antimicrobial Susceptibility Test Disks (FDA 510(k) Clearance)

Oct 2015
Decision
40d
Days
Class 2
Risk

K152516 is an FDA 510(k) clearance for the BD BBL Sensi-Disc Ceftazidime Avibactam (30/20ug), Antimicrobial Susceptibility Test Disks. This device is classified as a Susceptibility Test Discs, Antimicrobial (Class II - Special Controls, product code JTN).

Submitted by Becton, Dickinson and Company (Sparks, US). The FDA issued a Cleared decision on October 13, 2015, 40 days after receiving the submission on September 3, 2015.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1620.

Submission Details

510(k) Number K152516 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2015
Decision Date October 13, 2015
Days to Decision 40 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code JTN — Susceptibility Test Discs, Antimicrobial
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1620

Similar Devices — JTN Susceptibility Test Discs, Antimicrobial

All 8
HardyDisk AST Cefiderocol 30µg (FDC30)
K253105 · Hardy Diagnostics · Nov 2025
HardyDisk AST Gepotidacin 10µg (GEP10)
K250956 · Hardy Diagnostics · Jun 2025
HardyDisk Aztreonam/Avibactam 30/20µg (AZA50)
K250454 · Hardy Diagnostics · May 2025
HardyDisk AST Cefiderocol 30µg (FDC30)
K241060 · Hardy Diagnostics · Jul 2024
HardyDisk AST Sulbactam/Durlobactam 10/10µg (SUD20)
K231568 · Hardy Diagnostics · Jul 2023
BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)
K230651 · Becton, Dickinson and Company · Jun 2023